THROMBOCYTHEMIA ESSENTIAL
Clinical trials for THROMBOCYTHEMIA ESSENTIAL explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTHEMIA ESSENTIAL trials appear
Sign up with your email to follow new studies for THROMBOCYTHEMIA ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood cancer drug bomedemstat tested for Long-Term safety
Disease control Recruiting nowThis study follows about 400 people with certain blood cancers (like essential thrombocythemia and myelofibrosis) who are already taking bomedemstat and benefiting from it. The goal is to collect more information on the drug's long-term safety and how well it controls the disease…
Matched conditions: THROMBOCYTHEMIA ESSENTIAL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: THROMBOCYTHEMIA ESSENTIAL
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC